BENEFITS OF PHARMACOTHERAPEUTIC FOLLOW-UP FOR THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS: A INTEGRATIVE REVIEW. RECIMA21. 2021;2(9):e29726. doi:10.47820/recima21.v2i9.726